Real-time enrollment status for this arg1 deficiency clinical trial
Current Status
Recruiting
Checked: July 16, 2026 at 11:07 PM UTC
| NCT Number | NCT07573059 |
| Recruiting Status | Recruiting |
| Condition | ARG1 Deficiency |
| Phase | NA |
| Target Enrollment | 100 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Immedica Pharma US Inc |
| Last Updated on CT.gov | May 7, 2026 (May 7, 2026) |
As of July 16, 2026: Clinical trial NCT07573059 is currently recruiting participants. This na study for arg1 deficiency is actively seeking new participants at 1 location across the United States. The study is sponsored by Immedica Pharma US Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07573059 is actively recruiting participants as of July 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07573059 was last updated May 7, 2026 (May 7, 2026). HelloStudys verifies this status automatically.